عربي English Türkçe اردو فارسى
Logo
Latest News
Interviews

Astrazeneca: Our Vaccine Helped Save More Than One Million Lives

Mene Pangalos told Asharq Al-Awsat of aim to eliminate cancer as a cause of death

Mene Pangalos Executive Vice-President, BioPharmaceuticals R&D.
Mene Pangalos Executive Vice-President, BioPharmaceuticals R&D.
TT
TT

Astrazeneca: Our Vaccine Helped Save More Than One Million Lives

Mene Pangalos Executive Vice-President, BioPharmaceuticals R&D.
Mene Pangalos Executive Vice-President, BioPharmaceuticals R&D.

In the global fight against "Covid-19”, AstraZeneca has become a household name for millions of people around the world. It has supplied over 2.7 billion doses of the vaccine globally, with approximately two-thirds going to low- and middle-income countries, according to Mene Pangalos Executive Vice-President, BioPharmaceuticals R&D.

In a wide-ranging interview, Pangalos told Asharq Al-Awsat the vaccine has helped prevent 50 million Covid-19 cases, five million hospitalizations, and saved more than one million lives.

Pangalos also spoke of the company’s ambitious efforts to eliminate cancer as a cause of death. “We're leading a revolution to redefine cancer care”, he says, adding: “Through our Oncology R&D, we are pushing the boundaries of science to change the practice of medicine and transform the lives of patients living with cancer, with the aim of eliminating cancer as a cause of death”.

AstraZeneca has been a pioneer in the fight against Covid, particularly through the vaccine it developed with incredible speed with Oxford University. Tell us about that process.

Recognizing the urgent need for a safe and effective COVID-19 vaccine, in April 2020 we forged a landmark partnership with the University of Oxford which brought together their world-class expertise in vaccinology and our global development and manufacturing capabilities. Together we committed to providing the vaccine broadly and equitably across the globe, at no profit during the pandemic.

AstraZeneca has now supplied over 2.7 billion doses of the vaccine globally, with approximately two thirds going to low- and middle-income countries and over 420 million doses supplied through our partnership with the COVAX initiative.

To date over 65 million doses of the AstraZeneca Vaccine have been supplied to Arab countries.

Unlike other pharmaceutical companies, AstraZeneca did not make profits out of the sale of its vaccine. What was behind this decision, and when do you plan on raising your prices?

We are proud to have put broad and equitable access at the heart of our pandemic response. AstraZeneca and its partners have released for supply more than 2.7 billion vaccine doses to more than 180 countries across every continent, approximately two-thirds of these doses have gone to low- and lower-middle-income countries.

The vaccine has helped prevent 50 million COVID-19 cases, five million hospitalizations, and saved more than one million lives.

In 2022, we have moved to an affordable pricing approach around the world that enables us to maintain broad global access to the vaccine for the COVID-19 pandemic. This approach includes a tiered pricing approach aligned to Gross National Income (GNI) per capita, which is a widely recognized and implemented model used by developers of medicines and vaccines. We remain committed to supplying the vaccine at no profit to low-income countries.

Your ambitious R&D program states that “cures for cancer are within your grasp”. Tell us more about that.

At AstraZeneca, we are always striving, searching for new knowledge and the next breakthrough as we aim to have the greatest and swiftest impact on disease. Our pioneering R&D is focused on preventing, modifying and potentially curing disease, to deliver innovative, life-changing medicines for patients. Our R&D approach is evolving from pure symptom control to disease modification, focusing on earlier and smarter interventions that defy the natural course of disease. By reaching more patients earlier, we aim to slow disease progression and drive remission.

Our ambition in oncology is to provide cures for cancer in every form. We're not going to settle for standard of care or incremental improvements. We're leading a revolution to redefine cancer care. Through our Oncology R&D, we are pushing the boundaries of science to change the practice of medicine and transform the lives of patients living with cancer, with the aim of eliminating cancer as a cause of death. Our approach is to identify and treat patients earlier in the progress of their disease when there is potential for cure, and to improve the treatment of relapsed or refractory patients by addressing emerging resistant populations, particularly in later stages of the disease.

Our drug discovery and development is guided by our R&D Framework, which champions quality over quantity, and has helped transform the culture of medicine discovery and our business.

When it comes to cancer, we have one of the broadest and deepest oncology pipelines in the industry, based on six scientific platforms: Immuno-Oncology, DNA Damage Response, Antibody Drug Conjugates, Tumor Drivers and Resistance Mechanisms, Cell Therapies, and Epigenetics. With a focus on monotherapy and combinations, biomarker-driven innovative clinical trials and digital technologies, we are confident that cures for cancer are within our grasp.

But alongside our Oncology R&D organization we also have BioPharmaceuticals R&D, which is focused on Cardiovascular, Renal & Metabolism (CVRM), Respiratory & Immunology, and opportunistically, Neuroscience and Microbial Science.

The two organizations work together, sharing functions specializing in key scientific capabilities from medicinal chemistry to biometrics, patient safety to data science and artificial intelligence (AI), and clinical innovation to device technology. Collectively these enable us to accelerate our efforts to bring new medicines to patients.

How does your R&D program compare with that of other major pharmaceutical companies? And how do you plan on strengthening it across the globe?

In 2021 AstraZeneca invested $8 billion in R&D, around 21% of the Company’s turnover, in order to continue to discover and develop medicines which transform the lives of patients.

The Company has three world class strategic R&D centers including The Discovery Centre (DISC) in Cambridge in the UK, one in Gaithersburg, Maryland in the greater Washington, D.C. region of the US, and another in Gothenburg in Sweden, as well as further hubs across the world.

It has integrated R&D teams and accelerated decision-making processes, using its unique scientific capabilities, to deliver one of the most productive pipelines in the industry.

Since 2005, AstraZeneca has achieved an almost six-fold improvement in the proportion of its pipeline molecules that have advanced from preclinical investigation to completion of Phase III clinical trials – from 4% to 23%.

This improvement moves AstraZeneca well above the current industry average success rate of 14% in the 2018-2020 timeframe.

This is achieved through the combined efforts of 13,000 people at AstraZeneca who work exclusively in R&D, out of the Company’s 80,000 employees globally.

In 2021, AstraZeneca’s scientists published a total of 871 manuscripts, with 196 in high impact peer-review journals, compared to just one in 2010.

Tell us about the R&D Postdoctoral Challenge that you are launching. What are its main aims? And why have you chosen to announce it from Dubai?

The events of the past two years clearly show the need to push the boundaries of medical science has never been more urgent.

Rapid progress in disease understanding, as well as scientific and technological advances are genuinely changing our expectations of what is possible.

We are delighted to launch the R&D Postdoctoral Challenge to support the next generation of science leaders and help them translate their ideas into meaningful benefits for patients.

We chose to launch the post-doctoral challenge from the global platform of the World Expo 2020 in Dubai to underscore the truly global scope of this challenge.

We believe that geographic location should not pose a barrier to scientific exploration and are seeking proposals from outstanding candidates based anywhere around the world.

We are committed to attracting and retaining new talent, developing differentiated capabilities and skills, and creating new ways of working.

AstraZeneca holds an R&D presence in more than 40 countries across the globe, including strategic research centers in the UK, Sweden and the US, and development facilities in China and Japan.

The R&D Postdoctoral Challenge aims to discover transformative breakthroughs that hold a key to preventing, modifying, and hopefully in the future curing some of the world’s

most complex diseases. We’re inviting final year MD and/or Ph.D. students and Postdoctoral researchers to propose their innovative ideas that could help transform the treatment of some of the world’s most complex diseases.

Shortlisted applicants will have the opportunity to pitch their research proposals to a world-leading judging panel consisting of AstraZeneca and external life science leaders, with the potential to be awarded a fully funded postdoctoral position at AstraZeneca.

The judging panel will critique the proposals based on scientific merit, and opportunity to create real impact for patients, society and healthcare systems.

Successful candidates will join our vibrant scientific community within AstraZeneca, with access to the expertise, compounds, novel tools and technologies, and mentoring support they need to turn their ideas into reality.

Assigned both an academic and AstraZeneca mentor, successful candidates will have the freedom and autonomy to contribute known skills, plus the support to rapidly learn new approaches to follow the science, innovate and make an impact.

I’d also like to take this opportunity to highlight our Early talent programs.

We have a portfolio of high-quality early career programs supporting a diverse range of scientific talent at all stages of their professional development. Every year, we support more than 500 young scientists – including apprentices, undergraduate and graduate placements, PhDs and postdoctoral scientists.

· STEM Learning: Over 500 of our employees currently work as STEM (Science, Technology, Engineering and Mathematics) volunteers to inspire the next generation of scientist leaders and promote an understanding of the value and importance of global R&D towards creating a better, more sustainable society.

· School leavers: We are committed to supporting talent at the start of their careers, offering apprenticeships to gain practical experience of working in industry, plus outreach to schools to elevate awareness of roles in science.

· Graduates: Opportunities are provided to complete three different placements in two years across R&D, focusing on delivering breadth and depth of experience, career counselling and guidance.

· Postdoctoral research positions: Our two to three-year program funds postdoctoral projects to address fundamental scientific challenges that underpin drug discovery and development.

· Based on 2020 figures, across AstraZeneca there were >140 postdoctoral appointments of which >50% from world’s top 100 universities.

· Following the program, >95% of the postdoctoral alumni remained in science/technology and their scientific disciplines.

Does AstraZeneca have projects in the Arab world? Are you collaborating with particular universities, governments, companies? And on what projects?

AstraZeneca has a strong presence in and enduring commitment to the Arab world. We have continued to increase our footprint significantly through local partnerships and investments, as well as emphasizing our patient-centric approach in the form of local clinical trials and R&D.

Working hand-in-hand to tackle challenges within the healthcare sector by contributing to a robust healthcare ecosystem, our priorities are aligned with national health agendas.

We work closely with government officials, ministries and other healthcare bodies to ensure uninterrupted access to innovative medication for patients.

Our ambition is to reimagine healthcare – harnessing innovation to transform patients’ healthcare journeys to improve earlier diagnosis, more precision treatments and proactive digital monitoring for better outcomes, powered by digital, data and technology.

Our priorities remain to ensure the continued supply of our medicines to patients, and to safeguard the health and wellbeing of all, leaving no one behind.

Over 65 million doses of the AstraZeneca COVID-19 vaccine have been supplied to Arab countries through our partners.

UAE was the first country in the world to receive doses of our long-acting antibody combination, Evusheld, which offers pre-exposure protection from COVID-19. Egypt is also one of the earliest recipients of Evusheld doses.

How are you strengthening and supporting R&D across the world?

The A.Catalyst Network is an interconnected and dynamic global network of more than 20 AstraZeneca health innovation hubs, made up of physical locations and virtual partnerships. It connects a range of stakeholders, including governments, start-up companies and technology partners, to work inclusively and collaboratively to accelerate innovation, increase healthcare access and improve outcomes for patients and society. Each A.Catalyst Network hub has its own unique ecosystem, addresses different challenges, and can take different forms, depending on its local characteristics and needs.

We launched a hub in the GCC following the signing of an MoU with UK-based innovation partners, Gendius, in 2020. The A.Catalyst Network GCC hub provides access to a wealth of resources and information from partners around the globe. The HealthGATE application (a digital service designed to support the education, diagnosis and treatment of patients) and the expansion of EduGATE (a digital community of local HCPs with access to innovative tools and enhanced learning), enhance integration within this comprehensive biomedical ecosystem, furthering local medical capabilities, improving the abilities of healthcare practitioners and the lives of patients.

We currently have >2,000 active collaborations to accelerate drug discovery globally with academia, biotech companies, industry peers, healthcare systems and governments: 1,200 in Europe, 600 in the US and 130 in the Asia Pacific region.

Our Open Innovation programme offers a permeable research environment where scientists both inside and outside of AstraZeneca can share their ideas and collaborate on projects. Since its launch in 2014, we have reviewed more than 1000 proposals from scientists in 40 countries across six continents, and collaborators have been awarded US$75 million in grant funding to support their research projects using AstraZeneca assets. The Open Innovation portfolio currently features 35 ongoing or planned clinical trials and more than 425 pre-clinical studies.

Most Viewed

 
 
Interviews

Lebanon’s Foreign Minister to Asharq Al-Awsat: Only the State Decides on Talks with Israel

Lebanese Foreign Minister Youssef Raggi - File Photo
Lebanese Foreign Minister Youssef Raggi - File Photo
TT
TT

Lebanon’s Foreign Minister to Asharq Al-Awsat: Only the State Decides on Talks with Israel

Lebanese Foreign Minister Youssef Raggi - File Photo
Lebanese Foreign Minister Youssef Raggi - File Photo

Lebanese Foreign Minister Youssef Raggi said Lebanon “has started to gradually reclaim its natural right to determine its own fate independently of others’ calculations,” stressing that the Lebanese state “alone holds the decision to negotiate,” and that Lebanon “is not subordinate to anyone and is not a card in the hands of any axis.”

He expressed regret that the state’s efforts to secure financial and political support for reconstruction “are being confronted by an internal party, Hezbollah, which continues to gamble with the fate of these villages and their residents in service of goals and agendas unrelated to the national interest or to the suffering of the people of the south.”

In an interview with Asharq Al-Awsat, Raggi said that “the national priority today is to fully restore sovereignty, without diminution,” adding that “there is no shame in the Lebanese state negotiating with Israel if the goal is to end the war and recover territory.”

He also condemned “what has been uncovered of roving sabotage networks linked to Hezbollah in a number of Arab countries,” while at the same time denouncing the targeting of brotherly Arab states and their security and stability.

 

Lebanese Minister of Foreign Affairs and Emigrants Youssef Raggi (L) meets UN Under-Secretary-General for Peace Operations Jean-Pierre Lacroix (R) at the Lebanese Foreign Ministry in Beirut, Lebanon, 07 January 2026. Lacroix is on an official visit to meet Lebanon's leaders. EPA/WAEL HAMZEH

Negotiations exclusively in the hands of the state

The Lebanese ambassador to Washington, Nada Hamadeh Mouawad, held a second direct meeting with her Israeli counterpart, Yechiel Leiter, at the US State Department to discuss extending the truce and to set a date and venue for negotiations between the two delegations, in what is the first track of direct talks since 1993.

Raggi noted: “Iran dragged Lebanon into a war that was neither the choice of the Lebanese state nor of the majority of the Lebanese, but was imposed on it under an approach that treats Lebanon as a pressure card to be used at regional and international negotiating tables.”

He continued: “This led to the step taken by President Joseph Aoun to pursue a path of direct negotiations, clearly declaring that the Lebanese state alone holds the decision to negotiate, and that Lebanon is not subordinate to anyone and is not a card in the hands of any axis.” He stressed that “this step is not limited to its negotiating dimension, but lays the groundwork for restoring independent national decision-making and reinstating the concept of the state as the sole reference in war, peace, and foreign policy.”

Raggi reaffirmed that “the Lebanese track is now separate from the Iranian track,” and that “Lebanon’s interests are no longer hostage to the progress or deadlock of Iranian negotiations,” noting that “the second preparatory meeting is being held while talks related to Iran are facing stagnation and complications, which proves that Lebanon has begun to gradually reclaim its natural right to determine its own fate independently of others’ calculations.”He said: “This is a pivotal moment in Lebanon’s modern history, as it ends a long phase in which national milestones were tied to external agendas.”

No longer an arena

Raggi said: “We will no longer accept using Lebanon as an arena for settling regional scores or as a platform for military and political adventurism whose cost is borne by the Lebanese in their security, economy, and national unity.” He explained: “Experience has shown that turning Lebanon into an open arena for conflict has brought it nothing but destruction, isolation, and collapse. What is required today is to reassert its position as a sovereign state, not as a sphere of influence or a permanent front line.”

Lebanese President Joseph Aoun holding talks with Foreign Minister Youssef Raggi (Presidency)

Objectives of negotiations

On the objectives of negotiations, Raggi said that “Lebanon’s move toward negotiations is intended to address outstanding issues between the two countries, foremost among them border, security, and humanitarian matters,” stressing that “negotiation is not surrender, as some try to portray it, but a tool for defending national interests when conducted from a position of state authority and with careful calculation.”He added: “The balance of power is not measured only in weapons, but also in the legitimacy of the state, unity of the national position, international support, and the ability to use law and diplomacy to protect rights.”

He noted that “it is a grave mistake to portray Lebanon as being in a position of absolute weakness, just as it is equally wrong to portray it as being in a position of surrender. The reality is that Lebanon, if its institutions are unified, can negotiate from a clear national-interest position.”

Raggi added: “The national priority today is to fully restore sovereignty, without diminution. There is no shame in the Lebanese state negotiating with Israel if the goal is to end the war, recover territory, and secure a lasting peace that preserves the dignity of the Lebanese and prevents the recurrence of tragedies, especially for our people in the south who have paid a heavy price in lives, homes, and livelihoods.”

He continued: “The futile adventures carried out through what are called ‘proxies’ have proven that their outcome was neither liberation nor victory, but further fragmentation and weakening of the Lebanese state and depletion of its society and economy.”

Monopoly of arms

Raggi said Lebanon “has long delayed implementing governmental and constitutional decisions related to restricting weapons to the state, particularly Hezbollah’s arms, at a time when the majority of Lebanese are calling for a real state that alone holds the right to use force.” He added: “Restricting arms is not a political demand by one side against another; it is the only gateway to building a modern state, because the very concept of the state fundamentally contradicts the existence of armed groups outside its authority. A state cannot exist with two sets of arms, two sovereignties, or two decisions on war and peace.”

He pointed out that “facts have shown that weapons outside state control did not liberate occupied land, did not protect Lebanese citizens, and did not prevent destruction; rather, they deepened national losses.”

He explained: “Before the ‘support for Gaza’ war and linking Lebanon to the Iranian confrontation, the disputed border points were limited and confined to known issues, including the thirteen points, the Shebaa Farms, and the Kfar Shouba hills. After October 7, 2023, Israeli occupation expanded inside Lebanese territory at five points, and after March 2, the occupied areas widened further, while dozens of villages were destroyed and vast areas suffered devastation and displacement.”

He added: “This catastrophic outcome confirms that the logic of uncontrolled arms did not produce protection; rather, Hezbollah’s war calculus ultimately imposed the path of direct negotiations as the only way to recover what Lebanon has lost.”

Lebanese Foreign Minister Youssef Raggi - AFP

Targeting Arab states

Raggi strongly condemned “the discovery of roving sabotage networks linked to Hezbollah in a number of Arab countries.” He said: “This behavior is another example of the nature of the cross-border Iranian project, and its danger is not limited to Lebanon’s sovereignty but also extends to the security of sister and friendly states that have long stood by Lebanon in its most difficult times.”

He added: “We have informed our friends in the concerned countries of Lebanon’s full readiness for judicial and security cooperation, to pursue those responsible for these networks and provide all necessary assistance. We also reiterate our absolute rejection of using Lebanese territory or any Lebanese entity to harm the security of any Arab or friendly country.”

Hezbollah ‘gambling with the south’

Meanwhile, Israel continues explosions in border villages in the south. Raggi said: “We are closely following developments on the ground in the south, particularly the security belt imposed by Israel. The Foreign Ministry is working through all available diplomatic channels to achieve a full Israeli withdrawal, ensure residents can return to their villages, and launch reconstruction.”

He added: “But it is regrettable that while the state seeks to secure financial and political support for rebuilding, it faces an internal party, Hezbollah, that continues to gamble with the fate of these villages and their residents in service of goals and agendas unrelated to Lebanon’s interest or the suffering of the people of the south.”

Raggi said: “The painful scene of destroyed villages in the south, and of residents who have lost their homes, livelihoods, and sense of safety, should be a moment for courageous national reassessment,” stressing that “those who caused this war and dragged Lebanon into it against the will of its people must bear their political, moral, and historical responsibility and review their calculations before it is too late.”

Raggi affirmed that “Lebanon can no longer bear others’ wars, their projects, or illusions of victory that bring only ruin.” He concluded: “The future must belong to the state, to sovereignty, and to a just peace that protects all Lebanese.”

Interviews

Healey to Asharq Al-Awsat: UK Has More Jets Flying in the Region Than at Any Time in the Last 15 Years

British Secretary of State for Defense John Healey arrives for a cabinet meeting at 10 Downing Street in London, Britain, 24 March 2026. EPA/ANDY RAIN
British Secretary of State for Defense John Healey arrives for a cabinet meeting at 10 Downing Street in London, Britain, 24 March 2026. EPA/ANDY RAIN
TT
TT

Healey to Asharq Al-Awsat: UK Has More Jets Flying in the Region Than at Any Time in the Last 15 Years

British Secretary of State for Defense John Healey arrives for a cabinet meeting at 10 Downing Street in London, Britain, 24 March 2026. EPA/ANDY RAIN
British Secretary of State for Defense John Healey arrives for a cabinet meeting at 10 Downing Street in London, Britain, 24 March 2026. EPA/ANDY RAIN

British Defense Secretary John Healey revealed Wednesday that UK pilots and aircrew have flown over 1,200 hours on defensive missions across the Middle East since the conflict with Iran erupted, saying they have now had over 80 engagements together with RAF Regiment Gunners.

In an interview with Asharq Al-Awsat following his visit to Saudi Arabia, Healey said that the UK has around 1,000 personnel in the region and an extra 500 air defense personnel in Cyprus.

“I continue to work closely with our partners in the region on what further support we can provide,” he said, lauding the UK-Saudi Arabia defense partnership which he said is “founded on mutual security interests and longstanding industrial collaboration.”

“Although our friendship is historic, it has evolved into a modern partnership that responds to contemporary challenges,” he added.

On ties between Moscow and Iran, Healey did not rule out a hidden Russian hand behind some of the Iranian tactics.

The following are the key points from the interview:

80 engagements

“UK pilots and aircrew have flown over 1,200 hours on defensive missions across the region. Together with our RAF Regiment Gunners, they have now had over 80 engagements since the conflict began,” said Healey.

“I am proud of the work that our UK Armed Forces are doing alongside our Gulf partners to help keep people safe in the region. Their dedication and professionalism is helping to save lives as Iran indiscriminately targets countries across the Gulf,” he added.

Heavy Deployment

“The UK has around 1,000 personnel deployed to the region, not including our personnel in Cyprus,” he told Asharq Al-Awsat. “Force protection is at the highest levels for UK bases in the region.”

“We have more UK jets flying in the region than at any time in the last 15 years. We are undertaking defensive counter air operations over Bahrain, Jordan, Qatar, and the UAE as well as Cyprus,” he said.

“Since January, I have deployed extra equipment and people to the region. This includes Typhoon and F-35 jets, Wildcat helicopters armed with purpose-built counter-drone Martlet missiles, a Merlin Crowsnest helicopter, providing airborne surveillance and control plus radar systems, air defense systems and counter-drone units.”

He added that there are now an extra 500 air defense personnel in Cyprus, and the warship, HMS Dragon - which is fully integrated within the layered air defense system with allies and partners - is deployed in the Eastern Mediterranean.

Defense Systems to Support the Gulf

“I continue to work closely with our partners in the region on what further support we can provide, which was the purpose of my visit (to Riyadh) this week,” Healey told Asharq Al-Awsat.

“I confirmed during my meeting with the Defense Minister, His Royal Highness Prince Khalid bin Salman Al Saud, that we will deploy Sky Sabre to the Kingdom of Saudi Arabia - an air defense system that will be integrated into Saudi Arabia’s defenses to support Saudi Arabia's efforts in repelling Iran's attacks,” he added.

He also said that Rapid Sentry – a system made up of a radar and a missile launcher – was deployed to Kuwait, and Lightweight Multiple Launchers to Bahrain.

“We have extended the operations of our jets in Qatar which are flying defensive missions every night, and through Taskforce Sabre we're ensuring UK industry steps up too. The Taskforce brings together industry who offer counter drone and air defense capabilities with governments, including Gulf partners ... to rapidly provide them with the equipment they need.”

Advanced defense partnership with Saudi Arabia

On his visit to Saudi Arabia, he said the trip was aimed at showing support “during this period of sustained and indiscriminate Iranian attacks, and also to discuss further cooperation between our nations to protect our people and our shared interests in the Kingdom. That's why I was delighted to meet with His Royal Highness Prince Khalid bin Salman to discuss recent events in the region.”

“The UK and Saudi Arabia have a close, longstanding friendship, and share a decades-long defense partnership, founded on mutual security interests and longstanding industrial collaboration.”

That friendship “has evolved into a modern partnership that responds to contemporary challenges. This really matters in times like today: it means we have the trust and the shared understanding to respond quickly and decisively when the security environment demands it. It is precisely because of that deep foundation that we are able to act as we have done, such as deploying Sky Sabre to Saudi Arabia.”

Russian-Iranian cooperation

On Russia’s role in the Iran war, Healey said: “Our assessment is that, even prior to US and Israeli strikes, Russia highly likely shared intelligence and provided training to Iran, including on things such as drone technology and operations, and electronic warfare. And our intelligence also indicates that this cooperation is ongoing.”

“No one will be surprised that Putin’s hidden hand may be behind some of the Iranian tactics and potentially some of their capabilities as well. We see an axis of aggression between Russia and Iran - two countries that menace their neighbors and that pose a threat more widely to us all.”

No assessment on targeting Europe

Healey said that there is no assessment Iran is trying to target Europe with missiles. “Even if they did, we have the resources and alliances we need to keep the UK and our allies safe from any kind of attacks, whether it's on our soil or from abroad. The UK stands ready 24/7 to defend itself and protection of forces is at the highest levels for our bases in the region.”

Interviews

Spain’s FM Backs Saudi Arabia, Tells Asharq Al-Awsat that Iranian Attacks Are ‘Unjustified’

Spanish Foreign Minister Jose Manuel Albares. Photo: Foreign Ministry
Spanish Foreign Minister Jose Manuel Albares. Photo: Foreign Ministry
TT
TT

Spain’s FM Backs Saudi Arabia, Tells Asharq Al-Awsat that Iranian Attacks Are ‘Unjustified’

Spanish Foreign Minister Jose Manuel Albares. Photo: Foreign Ministry
Spanish Foreign Minister Jose Manuel Albares. Photo: Foreign Ministry

Spanish Foreign Minister Jose Manuel Albares has expressed Madrid’s support to Saudi Arabia, describing Iranian attacks on the Kingdom and other countries in the Gulf as “unjustified.”

In an interview with Asharq Al-Awsat published Thursday, the minister revealed that efforts were being exerted by Spain as part of several European countries and in coordination with nations in the Middle East to de-escalate, resort to diplomacy and put an end to the US-Israeli-Iranian war.

Albares said “Spain has openly condemned” the Iranian attacks and summoned Iran’s ambassador to convey “its firm rejection of violence.”

The Spanish Foreign Ministry also “called for an immediate cessation of these attacks," he said.

“The attacks conducted by Iran are completely unjustified,” Albares told Asharq Al-Awsat, while stressing full solidarity with Saudi Arabia and other Gulf countries against the Iranian attacks.

Saudi Crown Prince Mohammed bin Salman has recently received a phone call from the Spanish Prime Minister, Pedro Sanchez, who expressed “Spain’s support and solidarity in light of the unjustified attacks that the country is suffering.”

“Spain's stance is firmly rooted in defending international law and the United Nations Charter, rather than the principle of might makes right,” said Albares.

This message has been conveyed to Saudi Arabia, Bahrain, Kuwait, the United Arab Emirates, Oman, Qatar, Jordan, Türkiye, Egypt, Uzbekistan and Azerbaijan, he added.

Call for de-escalation and negotiation

“Spain advocates de-escalation, negotiation, and respect for international law. Our voice aims to bring reason and restraint to the current situation. We cannot accept the idea of war becoming a means by which countries interact with one another or a mechanism for establishing a balance of power in the Middle East. Violence never brings peace, stability or democracy; it only creates more violence and chaos,” said the minister.

“In light of this military escalation, Spain is acting coherently in accordance with the values of peace and solidarity that define Spanish society — values that are also shared by the majority of European states. Our country makes its decisions in line with European principles, the UN Charter, and international law,” he added.

The war has already had consequences that extend beyond the Middle East. For example, it has affected Cyprus and Türkiye, he said, warning that this increases the risk of the ongoing conflict spreading beyond the region.

The minister told Asharq Al-Awsat that the war is also affecting international trade and production of energy, which have a direct impact on global economies and geopolitics.

“The unpredictable consequences of the current conflict are making the situation extremely dangerous for the security and stability of the Middle East, including the Gulf states, which are being particularly targeted,” he said in response to a question.

Countries involved in the confrontation

Albares spoke about the situation of several countries in the region, including Lebanon, which he said “is facing a dramatic situation with numbers of victims increasing daily, an overstretched medical system incapable to attend them, more than a million of displaced people, and the destruction of civil infrastructure. The life of the people of Lebanon is disappearing before their eyes.”

He said Spain has condemned the attacks carried out by Hezbollah, that are fueling the spiral of confrontation, as well as Israel's attacks. “An Israeli land invasion is already ongoing, a grave error in a country that has already endured immense suffering.”

“We cannot ignore the attacks by Israel and non-State actors on UN forces, on UNIFIL, in which Spain has a significant presence, nor the repeated violations of international humanitarian law," Albares said.

The minister also expressed concern over the situation in Gaza and the West Bank. “There is no clear vision for the future, and humanitarian aid is not reaching the area, with access blocked and NGOs and humanitarian actors prevented to operate on the ground. In the West Bank in particular, settlement expansion and settler violence continues to increase with impunity,” he said.

High-risk situation defined by an unpredictable conflict

“We are facing an escalation of violence that has already killed thousands of people and negatively impacted maritime navigation in the Strait of Hormuz, and critical energy infrastructures, with direct consequences for global energy security,” he said.

“In short, it is an extremely high-risk situation defined by an unpredictable conflict that poses a direct threat to the security and stability of the Middle East, with repercussions that can be felt across the globe,” he added.

Asked about his views of the Gulf's concern about the war’s repercussions, Albares said: “Spain fully understands the Gulf countries' concerns about the consequences of this war. This has been reflected in the diplomatic outreach that I have conducted with my counterparts in the region.”

“Increasing insecurity in countries under attack from missiles and drones without justification — attacks that Spain firmly condemns — particularly those launched by Iran, contribute to an increasingly dangerous and complex situation. In this context, Spain advocates clear de-escalation, negotiation and respect for international law, insisting that we must avoid anything that adds to the tension.”

He added that “the situation in the Strait of Hormuz is also extremely worrying, as its impact on energy security and international trade is clear.”

He stressed that the conflict has human and humanitarian dimensions, such as loss of life and displacement, warning that this could have direct consequences also in Europe. So, he called for “a responsible solution based on solidarity.”

Unified position

“The only clear thing is that a response is necessary, and in this sense, Spain supports a response based on the unity of the international community around the universal applicability and respect of International law and the UN Charter,” said Albares.

Asked to what extent the current situation is likely to explode into a broader war,” the minister said: “The consequences of the actions of Israel, as well as Iran’s response, are unpredictable. We are entering a situation that makes it difficult to determine where the escalation could lead and what the ultimate effects could be.”